• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » anxiety

Articles Tagged with ''anxiety''

Fact Sheet

Alprazolam (Xanax) Fact Sheet for General Psychiatry

January 1, 2026
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Alprazolam is fast acting and effective for generalized anxiety disorder (GAD) and panic disorder, but its short duration of action may contribute to breakthrough symptoms between doses and make withdrawal more difficult.




Read More
CCPR_QA2 Mary Baker-Ericzen_photo_sm.png
Expert Q&A

Autism and the Transition to Adulthood: A Clinical Guide

January 1, 2026
Mary Baker-Ericzen, MA, PhD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Mary Baker-Ericzen, MA, PhD

Research professor at San Diego State University; operations director and research scientist at the Child and Adolescent Services Research Center; and scientist at the Interwork Institute. Director and clinical psychologist, Intricate Mind Institute, San Diego, CA.

Dr. Baker-Ericzen has no financial relationships with companies related to this material. 

The shift from school-based services to adult systems can feel like a cliff for autistic youth. Dr. Baker-Ericzen explains how to strengthen executive functioning, promote supported decision-making, and address anxiety early—helping young people build autonomy, confidence, and meaningful adult outcomes.


Read More
shutterstock_2716774959.jpg

Wounded Healers: Psychosis, Spirituality, and Jung

December 22, 2025
Chris Aiken, MD and Kellie Newsome, PMHNP

Are psychosis and OCD ever normal? We explore this question from Carl Jung’s breakdown to a new neurologic condition, hyperphantasia. 



Read More
shutterstock_2714175187.jpg

Wounded Healers: Freud and Jung

December 15, 2025
Chris Aiken, MD and Kellie Newsome, PMHNP

Some of the people who revolutionized psychiatry lived with mental illness themselves.



Read More
shutterstock_2700377353.jpg

TMS, Teens, and Antidepressants

November 10, 2025
Chris Aiken, MD and Kellie Newsome, PMHNP

Owen Muir, MD, believes TMS ought to come before antidepressants for many teens with depression, but does the FDA agree with him?



Read More
Fact Sheet

Propranolol (Inderal) Fact Sheet

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Propranolol has several uses in psychiatry, including performance anxiety, drug-induced tremor, and akathisia.




Read More
Fact Sheet

Lavender Essential Oil (CalmAid, Silexan) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Lavender essential oil (Silexan) is a well-tolerated, over-the-counter option for mild to moderate generalized anxiety disorder (GAD), supported by studies showing effect sizes comparable to standard treatments.




Read More
Fact Sheet

Gabapentin (Gralise, Horizant, Neurontin) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Gabapentin used to be considered a nonaddictive medication for anxiety and for alcohol dependence, but we now know it may be misused and diverted for its euphoriant effect.




Read More
Fact Sheet

Daridorexant (Quviviq) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Diazepam has a long history of use with good efficacy for anxiety. Its long half-life makes it a particularly effective anxiolytic for some patients, and it is a good alternative to chlordiazepoxide for alcohol withdrawal.




Read More
Fact Sheet

Dexmedetomidine (Igalmi) Fact Sheet for General Psychiatry

November 3, 2025
Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Dexmedetomidine is an alpha-2 agonist (think clonidine) that is used at higher doses intravenously (IV) (as Precedex) for ICU sedation.




Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • RogerSolomon2023.jpg
    General Psychiatry

    EMDR in Practice: A Clinician's Guide to Trauma Reprocessing with Roger Solomon, PhD

    Dr. Roger Solomon provides a comprehensive introduction to Eye Movement Desensitization and Reprocessing (EMDR).

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.